Back to Market Feed

Product Information

TRESIBA FLEXTOUCH 200 UNIT/ML is a brand product labeled by Novo Nordisk, priced at $18.0721 per ML under NDC 00169255013. Its NADAC has been published 544 times since Mar 23, 2016.

TRESIBA FLEXTOUCH 200 UNIT/ML

insulin degludec
$18.0721per ML

Strength

200 U/mL

Manufacturer

Novo Nordisk

NDC

00169255013

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

INSULIN DEGLUDEC

Approval Type

Biologic (BLA)

FDA Application

BLA203314

On Market Since

9/25/2015

Pharmacological Classes

Insulin Analog
Insulin

Price Statistics

The NADAC for TRESIBA FLEXTOUCH 200 UNIT/ML has been published 544 times since Mar 23, 2016, and over the history we have for it it has declined 67.4%. The table below summarizes its recorded NADAC range and movement.

Current price$18.0721 per ML
All-time high$65.1977 (Oct 16, 2019)
All-time low$18.0613 (Jul 22, 2026)
52-week high$65.0504
52-week low$18.0613
Median price$65.0267
Average price$60.4609
Largest weekly change-72.2% (Jan 14, 2026)
Weeks tracked544
Tracking sinceMar 23, 2016

Price History

1W

+0.1%

1M

+0.1%

3M

-0.0%

6M

-0.1%

1Y

-72.2%

3Y

-72.2%

5Y

-72.2%

All

-67.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

INSULIN DEGLUDEC FLEXTOUCH 200 UNIT/ML PEN
Generic
73070050315•Novo Nordisk
$22.7408
+26% more

Related Drugs

Same classification

HUMULIN 70-30 VIAL
Brand
00002871501•Eli Lilly and Company
$4.2580
per ML
HUMULIN R 100 UNIT/ML VIAL
Brand
00002821501•Eli Lilly and Company
$4.2644
per ML
HUMULIN N 100 UNIT/ML VIAL
Brand
00002831501•Eli Lilly and Company
$4.2667
per ML
NOVOLIN N 100 UNIT/ML VIAL
Brand
00169183411•Novo Nordisk
$4.6211
per ML
NOVOLIN R 100 UNIT/ML VIAL
Brand
00169183311•Novo Nordisk
$4.6249
per ML
NOVOLIN 70-30 100 UNIT/ML VIAL
Brand
00169183711•Novo Nordisk
$4.6280
per ML
AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE
Brand
47918087490•Mannkind Corporation
$5.1813
per EA
NOVOLIN R 100 UNIT/ML FLEXPEN
Brand
00169300315•Novo Nordisk
$5.8156
per ML
NOVOLIN N 100 UNIT/ML FLEXPEN
Brand
00169300415•Novo Nordisk
$5.8235
per ML
NOVOLIN 70-30 FLEXPEN
Brand
00169300715•Novo Nordisk
$5.8265
per ML

Frequently asked questions

What is the NADAC price of TRESIBA FLEXTOUCH 200 UNIT/ML?

The current National Average Drug Acquisition Cost (NADAC) for TRESIBA FLEXTOUCH 200 UNIT/ML, manufactured by Novo Nordisk, is $18.0721 per ML (NDC 00169255013), effective Aug 19, 2026.

How has the price of TRESIBA FLEXTOUCH 200 UNIT/ML changed over time?

Over the history we have for it, the NADAC for TRESIBA FLEXTOUCH 200 UNIT/ML has declined 67.4%. It has been tracked across 544 weekly CMS publications since Mar 23, 2016.

What are the highest and lowest recorded NADAC prices for TRESIBA FLEXTOUCH 200 UNIT/ML?

Since Mar 23, 2016, the NADAC for TRESIBA FLEXTOUCH 200 UNIT/ML has ranged from a low of $18.0613 (Jul 22, 2026) to a high of $65.1977 (Oct 16, 2019), with a median of $65.0267 per ML.

Are there cheaper alternatives to TRESIBA FLEXTOUCH 200 UNIT/ML?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRESIBA FLEXTOUCH 200 UNIT/ML in a comparable dosage form, but none are currently priced below it.

Who manufactures TRESIBA FLEXTOUCH 200 UNIT/ML?

TRESIBA FLEXTOUCH 200 UNIT/ML (NDC 00169255013) is labeled by Novo Nordisk, and CMS classifies it as a brand product.